Leon Gervitz

468 total citations
15 papers, 360 citations indexed

About

Leon Gervitz is a scholar working on Cellular and Molecular Neuroscience, Genetics and Rheumatology. According to data from OpenAlex, Leon Gervitz has authored 15 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Genetics and 6 papers in Rheumatology. Recurrent topics in Leon Gervitz's work include Neuroscience and Neuropharmacology Research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Leon Gervitz is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Leon Gervitz collaborates with scholars based in United States, Germany and Switzerland. Leon Gervitz's co-authors include John C. Fowler, Jeffrey R. Curtis, Lucian Ionescu, D. G. Davies, Stephen Hall, Ronald van Vollenhoven, Luke Peterson, Roy Fleischmann, L. O. Lutherer and Christopher L. Cioffi and has published in prestigious journals such as The Lancet, The Journal of Physiology and Brain Research.

In The Last Decade

Leon Gervitz

15 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leon Gervitz United States 10 208 99 67 67 62 15 360
Elisa Tsao United States 11 438 2.1× 190 1.9× 8 0.1× 53 0.8× 10 0.2× 21 970
Yujun Pan China 11 79 0.4× 11 0.1× 9 0.1× 157 2.3× 82 1.3× 16 433
L. Marks United States 10 47 0.2× 29 0.3× 7 0.1× 37 0.6× 127 2.0× 23 448
Rachel Schot Netherlands 16 39 0.2× 29 0.3× 11 0.2× 21 0.3× 62 1.0× 35 686
S.-L. Vanhanen Finland 10 75 0.4× 7 0.1× 35 0.5× 20 0.3× 44 0.7× 12 467
Sema İçöz Türkiye 12 99 0.5× 22 0.2× 6 0.1× 47 0.7× 35 0.6× 21 455
Virginija Danylaité Karrenbauer Sweden 18 78 0.4× 11 0.1× 13 0.2× 144 2.1× 48 0.8× 31 684
Christoph Ott Germany 5 9 0.0× 44 0.4× 24 0.4× 33 0.5× 108 1.7× 7 504
Cristina Domínguez‐González Spain 13 133 0.6× 9 0.1× 7 0.1× 14 0.2× 111 1.8× 80 503
Stéphanie Bigou France 12 24 0.1× 12 0.1× 41 0.6× 23 0.3× 86 1.4× 16 583

Countries citing papers authored by Leon Gervitz

Since Specialization
Citations

This map shows the geographic impact of Leon Gervitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon Gervitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon Gervitz more than expected).

Fields of papers citing papers by Leon Gervitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leon Gervitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon Gervitz. The network helps show where Leon Gervitz may publish in the future.

Co-authorship network of co-authors of Leon Gervitz

This figure shows the co-authorship network connecting the top 25 collaborators of Leon Gervitz. A scholar is included among the top collaborators of Leon Gervitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leon Gervitz. Leon Gervitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Burmester, Gerd R, Vibeke Strand, Andrea Rubbert‐Roth, et al.. (2019). Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension. RMD Open. 5(2). e001017–e001017. 9 indexed citations
3.
Burmester, Gerd R, Howard Amital, Andrea Rubbert‐Roth, et al.. (2019). SAT0137 PATIENTS (PTS) SWITCHED TO SARILUMAB FROM ADALIMUMAB ACHIEVE CLINICALLY IMPORTANT IMPROVEMENTS IN RA DISEASE ACTIVITY: RESULTS FROM MONARCH TRIAL OPEN-LABEL EXTENSION (OLE). Annals of the Rheumatic Diseases. 78. 1138–1139. 2 indexed citations
4.
Burmester, Gerd‐Rüdiger, Bernard Combe, Jeffrey R. Curtis, et al.. (2016). Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study. The Lancet. 388(10061). 2763–2774. 134 indexed citations
5.
Curtis, Jeffrey R., Melvin Churchill, Alan Kivitz, et al.. (2015). A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol. Arthritis & Rheumatology. 67(12). 3104–3112. 19 indexed citations
6.
7.
8.
Curtis, Jeffrey R., L. Chen, K. Luijtens, et al.. (2011). Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: An analysis of individual patient‐level data. Arthritis & Rheumatism. 63(8). 2203–2208. 14 indexed citations
9.
Fowler, John C., et al.. (2003). Systemic Hypoxia and the Depression of Synaptic Transmission in Rat Hippocampus after Carotid Artery Occlusion. The Journal of Physiology. 550(3). 961–972. 24 indexed citations
10.
Gervitz, Leon, et al.. (2003). The effect of acute hypoxemia and hypotension on adenosine-mediated depression of evoked hippocampal synaptic transmission. Experimental Neurology. 182(2). 507–517. 11 indexed citations
11.
Gervitz, Leon, Demet Nalbant, Simon C. Williams, & John C. Fowler. (2002). Adenosine-mediated activation of Akt/protein kinase B in the rat hippocampus in vitro and in vivo. Neuroscience Letters. 328(2). 175–179. 22 indexed citations
12.
Gervitz, Leon, L. O. Lutherer, Margaret E. Hamilton, & John C. Fowler. (2002). Lack of central effects of peripherally administered adenosine A1 agonists on synaptic transmission in the rat hippocampus. Brain Research. 951(1). 141–145. 7 indexed citations
13.
Gervitz, Leon, L. O. Lutherer, D. G. Davies, James H. Pirch, & John C. Fowler. (2001). Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 280(3). R639–R645. 42 indexed citations
14.
Fowler, John C., Linda Partridge, & Leon Gervitz. (1999). Hydroxylamine blocks adenosine A1 receptor-mediated inhibition of synaptic transmission in rat hippocampus. Brain Research. 815(2). 414–418. 5 indexed citations
15.
Fowler, John C., Leon Gervitz, & Linda Partridge. (1999). Hydroxylamine blocks pre- but not postsynaptic adenosine A1 receptor-mediated actions in rat hippocampus. Brain Research. 837(1-2). 309–313. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Tsao Breakdown of academic impact, for papers by Yujun Pan Breakdown of academic impact, for papers by L. Marks Breakdown of academic impact, for papers by Rachel Schot Breakdown of academic impact, for papers by S.-L. Vanhanen Breakdown of academic impact, for papers by Sema İçöz Breakdown of academic impact, for papers by Virginija Danylaité Karrenbauer Breakdown of academic impact, for papers by Christoph Ott Breakdown of academic impact, for papers by Cristina Domínguez‐González Breakdown of academic impact, for papers by Stéphanie Bigou
Rankless by CCL
2026